FDA advisers vote to oppose Pfizer/BioNTech COVID-19 vaccine booster

FILE PHOTO: Family doctor Vera Maria Soditt vaccinates a patient at her home with a dose of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine in Cologne, Germany, March 28, 2021. REUTERS/Thilo Schmuelgen

(Reuters) – A panel of outside advisers to the U.S. Food and Drug Administration on Friday voted against approval of a booster dose of the Pfizer Inc/BioNTech SE COVID-19 vaccine for people aged 16 and older.

Source: Read Full Article